Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Sep;26(3):318–321. doi: 10.1128/aac.26.3.318

Ceftazidime as initial therapy for suspected bacterial infections in hospitalized pediatric patients.

M D Reed, C A O'Brien, S C Aronoff, J D Klinger, J L Blumer
PMCID: PMC176161  PMID: 6391368

Abstract

Ceftazidime, a new beta-lactam antibiotic, was used to treat 60 children with suspected bacterial infections occurring outside the central nervous system. The patients ranged in age from 0.1 to 21 years and received 30 mg of ceftazidime per kg up to a total single dose of 1 g administered every 8 h. Fifty-three pathogens were isolated from 43 children before the initiation of therapy. All children responded clinically, although one child failed bacteriologically and five children were considered colonized at the end of ceftazidime therapy. Adverse reactions associated with ceftazidime administration were primarily alterations in laboratory parameters and were clinically insignificant. Ceftazidime administered on an 8-h dosing regimen is effective monotherapy for the treatment of childhood infections.

Full text

PDF
318

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. C., Maurer M. J., Dajani A. S. Pneumococci relatively resistant to penicillin: a prevalence survey in children. J Pediatr. 1980 Dec;97(6):939–941. doi: 10.1016/s0022-3476(80)80426-4. [DOI] [PubMed] [Google Scholar]
  2. Aronoff S. C., Murdell D., O'Brien C. A., Klinger J. D., Reed M. D., Blumer J. L. Efficacy and safety of ceftriaxone in serious pediatric infections. Antimicrob Agents Chemother. 1983 Nov;24(5):663–666. doi: 10.1128/aac.24.5.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aronoff S. C., Scoles P. V. Treatment of childhood skeletal infections. Pediatr Clin North Am. 1983 Apr;30(2):271–280. doi: 10.1016/s0031-3955(16)34357-7. [DOI] [PubMed] [Google Scholar]
  4. Aronoff S. C., Thomford W., Bertino J. S., Speck W. T. Development of meningitis during therapy with cefamandole. Pediatrics. 1981 May;67(5):727–728. [PubMed] [Google Scholar]
  5. Bertino J. S., Jr, Speck W. T. The cephalosporin antibiotics. Pediatr Clin North Am. 1983 Feb;30(1):17–26. doi: 10.1016/s0031-3955(16)34316-4. [DOI] [PubMed] [Google Scholar]
  6. Chartrand S. A., Marks M. I., Roberts R., Jubelirer D. P., Plunket D. C. Development of Haemophilus influenzae meningitis in patients treated with cefamandole. J Pediatr. 1981 Jun;98(6):1003–1005. doi: 10.1016/s0022-3476(81)80618-x. [DOI] [PubMed] [Google Scholar]
  7. Eron L. J., Goldenberg R. I., Park C. H., Poretz D. M. Ceftazidime therapy of serious bacterial infections. Antimicrob Agents Chemother. 1983 Feb;23(2):236–241. doi: 10.1128/aac.23.2.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kafetzis D. A., Brater D. C., Kapiki A. N., Papas C. V., Dellagrammaticas H., Papadatos C. J. Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics. J Pediatr. 1982 Mar;100(3):483–489. doi: 10.1016/s0022-3476(82)80466-6. [DOI] [PubMed] [Google Scholar]
  9. Kercsmar C. M., Stern R. C., Reed M. D., Myers C. M., Murdell D., Blumer J. L. Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response. J Antimicrob Chemother. 1983 Jul;12 (Suppl A):289–295. doi: 10.1093/jac/12.suppl_a.289. [DOI] [PubMed] [Google Scholar]
  10. LeFrock J. L., Prince R. A., Leff R. D. Mechanism of action, antimicrobial activity, pharmacology, adverse effects, and clinical efficacy of cefotaxime. Pharmacotherapy. 1982 Jul-Aug;2(4):174–184. doi: 10.1002/j.1875-9114.1982.tb03185.x. [DOI] [PubMed] [Google Scholar]
  11. Long S. S. Treatment of acute pneumonia in infants and children. Pediatr Clin North Am. 1983 Apr;30(2):297–321. doi: 10.1016/s0031-3955(16)34359-0. [DOI] [PubMed] [Google Scholar]
  12. Nelson J. D. Cefuroxime: a cephalosporin with unique applicability to pediatric practice. Pediatr Infect Dis. 1983 Sep-Oct;2(5):394–396. [PubMed] [Google Scholar]
  13. Neu H. C., Labthavikul P. Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1982 Jan;21(1):11–18. doi: 10.1128/aac.21.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Norrby S. R. Ceftazidime in clinical practice - a summary. J Antimicrob Chemother. 1983 Jul;12 (Suppl A):405–408. doi: 10.1093/jac/12.suppl_a.405. [DOI] [PubMed] [Google Scholar]
  15. O'Callaghan C. H., Acred P., Harper P. B., Ryan D. M., Kirby S. M., Harding S. M. GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity. Antimicrob Agents Chemother. 1980 May;17(5):876–883. doi: 10.1128/aac.17.5.876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Papadatos C. J., Kafetzis D. A., Kanarios J. Cefotaxime in the treatment of severe paediatric infections. J Antimicrob Chemother. 1980 Sep;6 (Suppl A):243–248. doi: 10.1093/jac/6.suppl_a.243. [DOI] [PubMed] [Google Scholar]
  17. Reed M. D., Bertino J. S., Jr, Aronoff S. C., Speck W. T., Blumer J. L. Evaluation of moxalactam. Clin Pharm. 1982 Mar-Apr;1(2):124–134. [PubMed] [Google Scholar]
  18. Reed M. D., Rekate H. L., Aronoff S. C., Myers C. M., Blumer J. L. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children. Clin Pharm. 1983 Nov-Dec;2(6):558–563. [PubMed] [Google Scholar]
  19. Tanphaichitra D., Bussayanond A., Christensen O. The combination of pivmecillinam and pivampicillin in the treatment of acute enteric fever. J Antimicrob Chemother. 1981 Jul;8(1):23–28. doi: 10.1093/jac/8.1.23. [DOI] [PubMed] [Google Scholar]
  20. Uchiyama N., Greene G. R., Kitts D. B., Thrupp L. D. Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol. J Pediatr. 1980 Sep;97(3):421–424. doi: 10.1016/s0022-3476(80)80193-4. [DOI] [PubMed] [Google Scholar]
  21. Van Klingeren B., Van Wijngaarden L. J. Inhibition of beta-lactamase in penicillinase producing gonococci by clavulanic acid. J Antimicrob Chemother. 1981 Jul;8(1):79–80. doi: 10.1093/jac/8.1.79. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES